| Literature DB >> 29614804 |
Blessing Atim Aderibigbe1, Buhle Buyana2.
Abstract
Alginate is a biopolymer used in a variety of biomedical applications due to its favourable properties, such as biocompatibility and non-toxicity. It has been particularly attractive in wound healing applications to date. It can be tailored to materials with properties suitable for wound healing. Alginate has been used to prepare different forms of materials for wound dressings, such as hydrogels, films, wafers, foams, nanofibres, and in topical formulations. The wound dressings prepared from alginate are able to absorb excess wound fluid, maintain a physiologically moist environment, and minimize bacterial infections at the wound site. The therapeutic efficacy of these wound dressings is influenced by the ratio of other polymers used in combination with alginate, the nature of cross linkers used, the time of crosslinking, nature of excipients used, the incorporation of nanoparticles, and antibacterial agents. This review provides a comprehensive overview of the different forms of wound dressings containing alginate, in vitro, and in vivo results.Entities:
Keywords: alginate; biopolymers; films; foams; hydrogels; nanofibers; wound dressing
Year: 2018 PMID: 29614804 PMCID: PMC6027439 DOI: 10.3390/pharmaceutics10020042
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Barriers to effective treatment of wounds.
| Barriers | Examples |
|---|---|
| Educational factor | Poor quality of research, lack of appropriate training, ritualistic practice and lack of appropriate skills. |
| Organizational factor | Lack of standardisation of practice that is acceptable, lack of expert opinion, instability in the health services. |
| Clinical factor | Bacterial infection, hypersensitivity, malnutrition, poor tissue perfusion, copious exudate, too much or too little information on wound management. |
| Psychosocial factor | Social isolation resulting in depression and reduced motivation with treatment, pain resulting in loss of sufficient sleep and lack of self-care. |
Figure 1Phases of wound healing.
Figure 2Classification of wound dressings.
Figure 3Structure of α-l-guluronic and β-d-mannuronic alginate residues.
Commercially available alginate-based dressings.
| Commercially Available Alginate-Based Wound Dressings | Composition | Applications | References |
|---|---|---|---|
| Algicell™ | Sodium alginate, 1.4% silver | Diabetic foot ulcer, leg ulcers, pressure ulcers, donor sites, and traumatic and surgical wounds. | [ |
| AlgiSite M™ | Calcium alginate | Leg ulcers, pressure ulcers, diabetic foot ulcers and surgical wounds. | [ |
| Comfeel Plus™ | Sodium carboxymethylcellulose and calcium alginate | Ulcers such as venous leg ulcers, pressure ulcers; burns, donor sites, postoperative wounds and necrotic wounds. | [ |
| Kaltostat™ | Sodium alginate | Pressure ulcers, venous ulcers, diabetic ulcers, donor sites, and traumatic wounds. | [ |
| Sorbsan™ | Calcium alginate | Arterial, venous, and diabetic leg ulcers | [ |
| Tegagen™ | Sodium alginate | Diabetic and infected wounds. | [ |
| Guardix-SG® | Sodium alginate and poloxamer | To avoid post-operative adhesions in thyroid and spine surgeries. | [ |
| SeaSorb® | Calcium alginate | Good for high exuding wounds e.g., ulcers such as diabetic and leg pressure ulcers. | [ |
| Algivon® | Calcium alginate and Manuka honey | It eliminates odour and ideal for necrotic wounds and wounds with odours. | [ |
| FibracolTMPlus | Calcium alginate and collagen | Full and partial-thickness wounds, for ulcers such as pressure ulcers, venous ulcers, diabetic ulcers and second-degree burns. | [ |
| Hyalogran® | An ester of hyaluronic acid and sodium alginate | Used for ulcers, diabetic wounds, pressure sores, ischemic, necrotic wounds. | [ |
| Tromboguard® | Sodium alginate, calcium alginate, chitosan, polyurethane and silver cations | Used to stop bleeding in postoperative wounds, traumatic wounds, gun shots, skin graft donor sites, bleeding from accidents. | [ |
Figure 4Films for wound dressing.